Han, K <br/><br/>
Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence.  [electronic resource] 

 -  Clinical oncology (Royal College of Radiologists (Great Britain))  Apr 2012 
 - 183-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1433-2981 
<br/><br/><label>Standard No.: </label>10.1016/j.clon.2011.09.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--metabolism<br/>Breast Neoplasms--metabolism<br/>Carcinoma, Ductal, Breast--metabolism<br/>Carcinoma, Intraductal, Noninfiltrating--metabolism<br/>Female<br/>Humans<br/>Mastectomy, Segmental<br/>Middle Aged<br/>Neoplasm Invasiveness<br/>Neoplasm Recurrence, Local--diagnosis<br/>Neoplasm Staging<br/>Prognosis<br/>Receptor, ErbB-2--metabolism<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone--metabolism<br/>Survival Rate